Sanofi Genzyme Revenue and Competitors
Estimated Revenue & Valuation
- Sanofi Genzyme's estimated annual revenue is currently $1.9B per year. 0
- Sanofi Genzyme's total funding is $639M.
Employee Data
- 00
Sanofi Genzyme Competitors & Alternatives
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $0.2M | 1 | -99% | N/A | N/A |
#2 | $3.1M | 20 | 233% | N/A | N/A |
#3 | $21.5M | 125 | 18% | $351M | N/A |
#4 | $18M | 116 | 5% | $312.8M | N/A |
#5 | $235M | 269 | -43% | $340.9M | N/A |
#6 | $2.2M | 34 | 17% | N/A | N/A |
#7 | $6M | 40 | -9% | $176.5M | N/A |
#8 | $1.8M | 28 | 367% | N/A | N/A |
#9 | $109.4M | 706 | 14% | N/A | N/A |
#10 | $6.2M | 40 | 233% | N/A | N/A |
What Is Sanofi Genzyme?
Genzyme General develops and markets therapeutic products and diagnostic products and services. Genzyme General has five therapeutic products on the market and a strong pipeline of products in development focused on the treatment of genetic disorders and other chronic debilitating diseases with well-defined patient populations. Genzyme General is a division of the biotechnology company Genzyme Corporation.
keywords:N/A$639M
Total Funding
N/A
Number of Employees
$1.9B
Revenue (est)
N/A
Employee Growth %
N/A
Valuation
N/A
Accelerator
Sanofi Genzyme News
A startup that was spun out of Sanofi ADR in late 2019 is finally ready to share more about its work. Sionna Therapeutics, a cystic...
Sionna Therapeutics, a Sanofi Genzyme spinout, announced its launch with $111 million in Series B financing led by OrbiMed.
The life sciences giant Sanofi is now working from one of its two towers ... under the name Sanofi, subsuming offshoots like Sanofi Genzyme.
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $64.9M | 0 | N/A | $751.3M |
#2 | $9.5M | 0 | N/A | $138M |
#3 | $5.9M | 0 | N/A | $21.9M |
#4 | $8.8M | 0 | N/A | $6.8M |
#5 | $1.3M | 0 | N/A | N/A |